Next Article in Journal
Circulating MicroRNAs and Extracellular Vesicle-Derived MicroRNAs as Predictors of Functional Recovery in Ischemic Stroke Patients: A Systematic Review and Meta-Analysis
Next Article in Special Issue
Bacteriophages and the Microbiome in Dermatology: The Role of the Phageome and a Potential Therapeutic Strategy
Previous Article in Journal
Blockade of CB1 or Activation of CB2 Cannabinoid Receptors Is Differentially Efficacious in the Treatment of the Early Pathological Events in Streptozotocin-Induced Diabetic Rats
Previous Article in Special Issue
Intraspecific Diversity of Microbial Anti-Inflammatory Molecule (MAM) from Faecalibacterium prausnitzii
 
 
Article
Peer-Review Record

Probiotic Bifidobacterium longum subsp. longum Protects against Cigarette Smoke-Induced Inflammation in Mice

Int. J. Mol. Sci. 2023, 24(1), 252; https://doi.org/10.3390/ijms24010252
by Kurtis F. Budden 1, Shaan L. Gellatly 1, Annalicia Vaughan 2, Nadia Amorim 2, Jay C. Horvat 1, Nicole G. Hansbro 2, David L. A. Wood 3, Philip Hugenholtz 3, Paul G. Dennis 4, Peter A. B. Wark 1 and Philip M. Hansbro 1,2,*
Reviewer 1: Anonymous
Reviewer 2:
Int. J. Mol. Sci. 2023, 24(1), 252; https://doi.org/10.3390/ijms24010252
Submission received: 1 December 2022 / Revised: 18 December 2022 / Accepted: 20 December 2022 / Published: 23 December 2022
(This article belongs to the Special Issue Recent Advances and Future Perspective in Microbiota and Probiotics)

Round 1

Reviewer 1 Report

Summary of the paper

A manuscript by Budden et al. explores whether Bifidobacterium longum supplementation alleviates smoke-induced inflammation in mice. The authors demonstrate that supplementation of B. longum in mice is associated with reduced lung inflammation, inflammatory cytokine expression, and adhesion factor expression, and alleviated cigarette smoke-induced depletion in caecum butyrate. Overall, this work will be of interest to researchers and health professionals working in the field, given that the gut-lung axis is not often described in the literature. I only have some minor suggestions.

 

Minor remarks

·      Lines 17, 29, 32, 45: "Bifidobacteria". The correct name of the genus is Bifidobacterium

·      Line 49 and forward: please specify the subspecies of Bifidobacterium longum (it contains at least three different ones). I assume the authors meant Bifidobacterium longum subsp. longum

·      Figure 1F: indicate in the legend what is pointed by black arrows.

·      111-113: "Cigarette smoke exposure induced a trend towards increased total SCFA abundance (p=0.09) in vehicle-treated mice..."
Please rephrase or omit. Emphasizing observations that "trend towards statistical significance" is a misleading practice because it implies that increasing the sample size would result in better p-values, which is often not true (see https://doi.org/10.1136/bmj.g2215)

·      205-206: "Overall, this study demonstrates that both acetate- and non-acetate-producing B. longum"... Please rephrase. The BL0033 knockout strain is still capable of producing acetate (see the original Fukuda et al. paper)

·      Line 217-218: the strain did not "lack" the BL0033 gene; it was disrupted by insertional mutagenesis

Author Response

Please see the attachment

Author Response File: Author Response.docx

Reviewer 2 Report

The manuscript “Probiotic Bifidobacterium longum protects against cigarette smoke-induced inflammation in mice” by Budden et al. They have reported the anti-inflammatory effects Bifidobacterium longum against cigarette smoke using a mice model. The authors have done various parameters to prove their hypothesis. The manuscript is written in standard English with several grammatical and typographical errors. After thoroughly reviewing I feel the manuscript needs revision.

Comments:

1.     In the abstract section, I will suggest rewriting the conclusion in a better way.

2.     I will suggest adding briefly the reason behind the selection of acetate forming WT and KO B. longum in the introduction section.

3.     I will suggest that authors can see a few more inflammatory (IL6) and anti-inflammatory cytokines IL10.

4.     Authors have performed only gene expression to prove their hypothesis…I will suggest that authors can add western blot or ELISA that can add values to the data and manuscript.

 

5.     I will suggest adding a graphical abstract that can be the point of interaction for the readers.

Author Response

Please see the attachment

Author Response File: Author Response.pdf

Round 2

Reviewer 2 Report

Authors have responded my comments and suggestions positively.

Back to TopTop